These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 3704107
1. The management of pregnancy in Wilson's disease treated with trientine. Walshe JM. Q J Med; 1986 Jan; 58(225):81-7. PubMed ID: 3704107 [Abstract] [Full Text] [Related]
2. Pregnancy in Wilson's disease. Walshe JM. Q J Med; 1977 Jan; 46(181):73-83. PubMed ID: 866569 [Abstract] [Full Text] [Related]
7. Neurological abnormalities in Wilson's disease are reversible. Lingam S, Wilson J, Nazer H, Mowat AP. Neuropediatrics; 1987 Feb 04; 18(1):11-2. PubMed ID: 3561699 [Abstract] [Full Text] [Related]
8. Two male patients with Wilson's disease treated using trientine and iron reduction therapy. Hayashi H, Ueno T, Yano M, Okada T, Mabuchi H. J Gastroenterol Hepatol; 2005 Oct 04; 20(10):1627-8. PubMed ID: 16174091 [No Abstract] [Full Text] [Related]
9. [Treatment of Wilson's disease using triethylenetetramine dihydrochloride (TETA)]. Hauftová D, Körbel J, Jancík F, Kuhr I, Ferenc M. Cesk Gastroenterol Vyz; 1978 Dec 04; 32(8):538-9. PubMed ID: 737791 [No Abstract] [Full Text] [Related]
10. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report. Haslam RH, Sass-Kortsak A, Stout W, Berg M. Dev Pharmacol Ther; 1980 Dec 04; 1(5):318-24. PubMed ID: 7438976 [Abstract] [Full Text] [Related]
11. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu]. Günther K, Siegemund R, Lössner J, Kühn HJ. Radiobiol Radiother (Berl); 1988 Dec 04; 29(2):226-9. PubMed ID: 3399664 [No Abstract] [Full Text] [Related]
12. [Trientin in Wilson's disease. Therapeutic possibilities in patients who cannot tolerate penicillamine]. Ritland S. Tidsskr Nor Laegeforen; 1987 Aug 10; 107(22):1770-1. PubMed ID: 3660361 [No Abstract] [Full Text] [Related]
13. The management of Wilson's disease with trienthylene tetramine 2HC1 (Trien 2HC1). Walshe JM. Prog Clin Biol Res; 1979 Aug 10; 34():271-80. PubMed ID: 531055 [No Abstract] [Full Text] [Related]
14. [Triethylene tetramine in Wilson's disease]. Rave D, Vengrover D, Kleinman J, Leitersdorf E. Harefuah; 1986 Feb 16; 110(4):178-9. PubMed ID: 3721331 [No Abstract] [Full Text] [Related]
17. Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc. Askari FK, Greenson J, Dick RD, Johnson VD, Brewer GJ. J Lab Clin Med; 2003 Dec 16; 142(6):385-90. PubMed ID: 14713890 [Abstract] [Full Text] [Related]
19. [Wilson disease: a new case treated with trientine]. Moreno Pérez-Crespo JL, García de la Rocha ML, Martín Araguz A, Olmedilla N, Rodríguez Arias CA, Porta J, Moreno Martínez JM. Rev Neurol; 1995 Dec 16; 23(119):145-7. PubMed ID: 8548611 [Abstract] [Full Text] [Related]
20. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine). Dahlman T, Hartvig P, Löfholm M, Nordlinder H, Lööf L, Westermark K. QJM; 1995 Sep 16; 88(9):609-16. PubMed ID: 7583074 [Abstract] [Full Text] [Related] Page: [Next] [New Search]